The federal Food and Drug Administration has approved a clinical trial to involve 320 veterans, including Michigan residents, who have PTSD and past experience smoking marijuana.
The Multidisciplinary Association for Psychedelic Studies (MAPS) is conducting the phase II clinical trial. The state of Michigan is helping fund it via a $12.9 million grant to MAPS. Michigan has designated a portion of state marijuana tax revenue to contribute to mental health research for veterans. Some number of the study participants will be Michigan residents.
Read the article HERE.